Clinical Trial Update: Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia [NA]

View source ↗

Summary

A completed clinical trial evaluating bioelectrical impedance measurements to predict treatment outcomes in newly diagnosed acute leukemia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Mast Cell Leukemia
• Myeloid Nk-cell Acute Leukemia
• Undifferentiated Leukemia

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Acute Undifferentiated Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | NA | Status: COMPLETED | Results posted: 2020-04-27